Literature DB >> 18386140

Deaths from non-melanoma skin cancer in Western Australia.

J Girschik1, Lin Fritschi, T Threlfall, T Slevin.   

Abstract

OBJECTIVES: Non-melanoma skin cancer (NMSC) is common, slow growing, and rarely metastasizes. However, there are still nearly 400 deaths from NMSC in Australia annually. We aimed to investigate the accuracy of NMSC death coding and to describe the characteristics of these deaths and the potential for prevention.
METHODS: Histology reports for all deaths coded as NMSC (ICD-10 C44.0-C44.9) by the Western Australian Cancer Registry for the years 1996-2005 were reviewed for type of cancer, body site (primary tumor and metastases), and level of available documentation.
RESULTS: Of 368 deaths recorded as being due to NMSC only 3 were found to be miscoded. An additional 53 deaths contained inadequate information to confirm NMSC as the cause of death. Of the confirmed cases, 219 were due to squamous cell carcinoma, 53 to Merkel cell carcinomas, and 40 to other skin cancers. Cases were mainly males and were elderly. Most of the primary squamous and Merkel cell carcinomas were in areas of maximum sun exposure (face, ears, and hands, and scalp in males).
CONCLUSIONS: Misclassification of NMSC deaths in WA was minimal. The majority of NMSC deaths were due to squamous cell carcinomas; had primary sites associated with significant sun exposure; and occurred in older men.

Entities:  

Mesh:

Year:  2008        PMID: 18386140     DOI: 10.1007/s10552-008-9150-9

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  10 in total

1.  Quality of life and clinical and demographic characteristics of patients with cutaneous squamous cell carcinoma submitted to tumor resection by double-bladed scalpel.

Authors:  Daniel Ongaratto Barazzetti; Pedro Henrique Ongaratto Barazzetti; Bárbara Thomé Cavalheiro; Jorge Bins Ely; Daniel Holthausen Nunes; Ana Maria Nunes de Faria Stamm
Journal:  An Bras Dermatol       Date:  2019-07-29       Impact factor: 1.896

2.  P53 mutation is a rare event in Merkel cell carcinoma of the head and neck.

Authors:  Claudia Lill; Sven Schneider; Chike B Item; Robert Loewe; Roland Houben; Daniel Halbauer; Gregor Heiduschka; Markus Brunner; Dietmar Thurnher
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-02-18       Impact factor: 2.503

3.  Effect of an intervention on observed sun protection by vacationers in a randomized controlled trial at North American resorts.

Authors:  David B Buller; Peter A Andersen; Barbara J Walkosz; Michael D Scott; Larry Beck; Gary R Cutter
Journal:  Prev Med       Date:  2017-02-09       Impact factor: 4.018

4.  Rationale, design, samples, and baseline sun protection in a randomized trial on a skin cancer prevention intervention in resort environments.

Authors:  David B Buller; Peter A Andersen; Barbara J Walkosz; Michael D Scott; Larry Beck; Gary R Cutter
Journal:  Contemp Clin Trials       Date:  2015-11-22       Impact factor: 2.226

5.  Expression of β-catenin and cyclin D1 in Merkel cell carcinomas of the head and neck.

Authors:  Claudia Lill; Sven Schneider; Bahil Ghanim; Markus Brunner; Gregor Heiduschka; Robert Loewe; Dietmar Thurnher
Journal:  Wien Klin Wochenschr       Date:  2013-08-09       Impact factor: 1.704

6.  Statistical Survey of Deaths from Nonmelanoma Skin Cancer in Japan during 54 Years.

Authors:  Hisashi Ohtsuka
Journal:  J Skin Cancer       Date:  2011-01-16

7.  Merkel cell carcinoma: a population-based study on mortality and the association with other cancers.

Authors:  Valeria Ascoli; Giada Minelli; Mark Kanieff; Luisa Frova; Susanna Conti
Journal:  Cancer Causes Control       Date:  2011-08-20       Impact factor: 2.506

8.  Second cancer incidence and cancer mortality among chronic lymphocytic leukaemia patients: a population-based study.

Authors:  J A Royle; P D Baade; D Joske; J Girschik; L Fritschi
Journal:  Br J Cancer       Date:  2011-08-16       Impact factor: 7.640

9.  Triggering apoptotic death of human malignant melanoma a375.s2 cells by bufalin: involvement of caspase cascade-dependent and independent mitochondrial signaling pathways.

Authors:  Yu-Ping Hsiao; Chun-Shu Yu; Chien-Chih Yu; Jai-Sing Yang; Jo-Hua Chiang; Chi-Cheng Lu; Hui-Ying Huang; Nou-Ying Tang; Jen-Hung Yang; An-Cheng Huang; Jing-Gung Chung
Journal:  Evid Based Complement Alternat Med       Date:  2012-04-07       Impact factor: 2.629

Review 10.  Skin cancer, including related pathways and therapy and the role of luteolin derivatives as potential therapeutics.

Authors:  Aleksandra M Juszczak; Ute Wöelfle; Marijana Zovko Končić; Michał Tomczyk
Journal:  Med Res Rev       Date:  2022-02-21       Impact factor: 12.388

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.